Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation

M Chehelgerdi, M Chehelgerdi, OQB Allela… - Molecular cancer, 2023 - Springer
The use of nanotechnology has the potential to revolutionize the detection and treatment of
cancer. Developments in protein engineering and materials science have led to the …

[HTML][HTML] Bacterial CRISPR regions: general features and their potential for epidemiological molecular typing studies

Z Karimi, A Ahmadi, A Najafi… - The open microbiology …, 2018 - ncbi.nlm.nih.gov
Methods: These unique regions are diverse in number and sequence composition in
different pathogenic bacteria and thereby can be a suitable candidate for molecular …

Antibiotic resistance, virulence factors and genotyping of Uropathogenic Escherichia coli strains

M Raeispour, R Ranjbar - Antimicrobial Resistance & Infection Control, 2018 - Springer
Background The way of treating different types of infectious diseases is really important.
Using genotyping method, we can determine the genetic relatedness between the …

Evaluation of Genotype MTBDRplus and MTBDRsl Assays for Rapid Detection of Drug Resistance in Extensively Drug-Resistant Mycobacterium tuberculosis …

H Javed, Z Bakuła, M Pleń, HJ Hashmi, Z Tahir… - Frontiers in …, 2018 - frontiersin.org
Pakistan ranks 5th among the world's highest tuberculosis (TB) burden countries alongside
the 6th among countries with the highest burden of drug-resistant TB, including multi-drug …

Novel Mutations in pncA Gene of Pyrazinamide Resistant Clinical Isolates of Mycobacterium tuberculosis

M Kahbazi, H Sarmadian, A Ahmadi, F Didgar… - Scientia …, 2018 - mdpi.com
In clinical isolates of Mycobacterium tuberculosis (MTB), resistance to pyrazinamide occurs
by mutations in any positions of the pncA gene (NC_000962. 3) especially in nucleotides …

[PDF][PDF] Determination of principal genotypic groups among susceptible, MDR and XDR clinical isolates of Mycobacterium tuberculosis in Belarus and Iran

M Arjomandzadegan, LP Titov, LK Surkova, P Farnia… - Tuberk …, 2012 - academia.edu
Determination of principal genotypic groups among susceptible, MDR and XDR clinical isolates
of Mycobacterium tuberculosis in Be Page 1 153 Determination of principal genotypic groups …

Low rates of synonymous mutations in sequences of Mycobacterium tuberculosis GyrA and KatG genes

VV Khrustalev, M Arjomandzadegan, EV Barkovsky… - Tuberculosis, 2012 - Elsevier
Partial sequences of KatG and GyrA genes have been obtained from multi and extensively
drug-resistant (MDR and XDR) clinical isolates of Mycobacterium tuberculosis …

[HTML][HTML] Comparison of antibacterial effects of a carrier produced in microemulsion system from aqueous extract of Aloe vera with selected antibiotics on …

G Habibi, M Arjomandzadegan… - Iranian journal of …, 2018 - ncbi.nlm.nih.gov
Materials and Methods: The aquatic extract of Aleo vera was produced by the Soxhlet
method and a nonocarrier in the microemulsion system was prepared by two emulsifiers …

[PDF][PDF] Study of promoter and structural gene sequence of whiB7 in MDR and XDR forms of Mycobacterium tuberculosis

M Arjomandzadegan, M Sadrnia… - West indian medical …, 2011 - mona.uwi.edu
Resistance phenomenon in M tuberculosis is mainly based on decreased permeability of
the bacterial envelope and function of effluent pumps. The regulatory gene of the whiB7 …

[HTML][HTML] Predictive power of ETRE polymorphism and Katg463 mutation to INH-resistance of M. tuberculosis

YF Wen, C Jiang, XF Cheng, ZP Zhang… - Iranian Journal of …, 2015 - ncbi.nlm.nih.gov
Background: The MIRU-VNTR polymorphism and katG463 mutation are used to genotype
the mycobacterium tuberculosis, but the correlation between them and INH-resistance were …